Press Releases from GBI Research (17 total)
Diabetes and obesity therapeutics market will more than double to $163.2 billion …
Report Title: Global Diabetes and Obesity Drugs Market to 2022
The global market for diabetes mellitus and obesity is set to rise from $70.8 billion…
Glioblastoma market set for strong innovation, with 120 first-in-class programs
Glioblastoma, a particularly aggressive form of brain tumor, has a promising treatment pipeline, with 120 first-in-class programs acting on 86 first-in-class molecular targets. Adam Bradbury,…
Global drug delivery technologies market will reach $26 billion by 2020
The global market for drug delivery technologies will rise from $20 billion in 2015 to around $26 billion by 2020. Deekshita Allavarapu, Analyst for GBI…
Increased diagnoses of hemophilia A and B will drive Asia-Pacific market growth …
The hemophilia A and B markets in the Asia-Pacific (APAC) region are forecast to expand from $444.9 million and $76.3 million in 2015 to $699.1…
Cardiovascular disease market set to grow very slowly to $146.4 billion by 2022
The cardiovascular disease market, which includes hypertension, dyslipidemia, and thrombotic events, is set to grow from $129.2 billion in 2015 to $146.4 billion by 2022,…
Gastrointestinal drugs market to hit $48.4 billion by 2022 as biologic products …
The market size for gastrointestinal therapeutics is set to grow from $35.7 billion in 2015 to $48.4 billion by 2022, representing a compound annual growth…
Cancer vaccines market will soar to $7.5 billion by 2022, says GBI Research
The cancer vaccines market is set to almost triple from $2.5 billion in 2015 to $7.5 billion by 2022, representing a strong compound annual growth…
Global neurodegenerative drugs market set to hit $45 billion by 2022
Neurodegenerative disorders market, which covers Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease, and multiple sclerosis (MS), is set to grow from $27.2…
Cancer immunotherapies space to witness extraordinary growth, reaching $75.8 bil …
Report Title: Global Cancer Immunotherapies Market to 2022.
The market size for cancer immunotherapies is expected to grow more than fourfold from $16.9 billion in 2015…
Low innovation in hepatitis C therapies means significant unmet needs remain
Although recent years have seen a revolution in the hepatitis C space, as interferon-free direct-acting antiviral (DAA) combination therapies have started replacing interferon-based therapies, a…
Ophthalmology’s diverse pipeline could rejuvenate previously stagnant therapy …
Report Title: Frontier Pharma: Ophthalmology Therapeutics.
The ophthalmology market has experienced relatively little advancement in recent years and, with large unmet needs remaining in this…
Asia-Pacific gastric cancer market set to experience strong growth to $2.7 billi …
Report Title: Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies.
The Asia-Pacific (APAC) gastric…
Low innovation in hepatitis C therapies means significant unmet needs remain, sa …
Report Title: Frontier Pharma: Hepatitis C – Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations
Although recent years have seen a…
Global Viral Infections Market to Reach $117.6 Billion by 2021
Report Title: Global Viral Infections Market to 2021 – Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
Fiona Chisholm, Analyst for…
Asia-Pacific anti-hypertensive therapeutics market to hit $27 billion by 2022, d …
Report Title: Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 – Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
The market for anti-hypertensive therapeutics across…
Currently underserved melanoma therapeutics space offers promising pipeline, wit …
Ophthalmological disorders market, which is set to almost double from $13.7 billion in 2015 to $26 billion by 2022 at a compound annual growth rate…
Antibacterial drugs market will hit $35.6 billion by 2022, as efforts increase t …
The antibacterial drugs market is set to grow from $27.7 billion in 2015 to $35.6 billion by 2022, representing a compound annual growth rate of…
Go To Page:
